Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director
|
|
Arbutus Biopharma Corp (ABUS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| Rewolinski Melissa (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 110,000 options to buy
@ $0 |
|
| 07/12/2023 |
4
| Sims Karen (Chief Medical Officer) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 153,640 options to buy
@ $2.26, valued at
$347.2k
|
|
| 07/12/2023 |
4
| Naftzger J. Christopher (General Counsel and CCO) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 500,000 options to buy
@ $0 |
|
| 05/26/2023 |
4
| HENRIQUES RICHARD C JR (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 55,000 options to buy
@ $0 |
|
| 05/26/2023 |
4
| BURGESS DANIEL D (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 55,000 options to buy
@ $0 |
|
| 05/26/2023 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 55,000 options to buy
@ $0 |
|
| 05/26/2023 |
4
| Torti Frank (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 55,000 options to buy
@ $0 |
|
| 05/26/2023 |
4
| Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 55,000 options to buy
@ $0 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| HENRIQUES RICHARD C JR (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 41,000 options to buy
@ $0 |
|
| 05/26/2022 |
4
| BURGESS DANIEL D (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 41,000 options to buy
@ $0 |
|
| 05/26/2022 |
4
| Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 41,000 options to buy
@ $0 |
|
| 05/26/2022 |
4
| Torti Frank (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 41,000 options to buy
@ $0 |
|
| 05/26/2022 |
4
| Tran Tram (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 41,000 options to buy
@ $0 |
|
| 05/26/2022 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 41,000 options to buy
@ $0 |
|
| 01/20/2022 |
4
| Collier William H. (President and CEO) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 787,550 options to buy
@ $2.81, valued at
$2.2M
|
|
| 01/20/2022 |
4
| HASTINGS DAVID C (CFO) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 285,000 options to buy
@ $2.81, valued at
$800.9k
|
|
| 01/20/2022 |
4
| Howard Elizabeth (Chief Compliance Officer) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 237,500 options to buy
@ $2.81, valued at
$667.4k
|
|
| 01/20/2022 |
4
| Sofia Michael J. (Chief Scientific Officer) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 285,000 options to buy
@ $2.81, valued at
$800.9k
|
|
| 01/20/2022 |
4
| Picchio Gaston (Chief Development Officer) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 256,500 options to buy
@ $2.81, valued at
$720.8k
|
|
| 01/20/2022 |
4
| McElhaugh Michael J. (Chief Business Officer) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 325,850 options to buy
@ $2.81, valued at
$915.6k
|
|
| 12/03/2021 |
4
| Sofia Michael J. (Chief Scientific Officer) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Sold 200,000 shares
@ $5.09, valued at
$1M
|
|
| 11/12/2021 |
4
| Tran Tram (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 44,000 options to buy
@ $0 |
|
| 10/20/2021 |
4
| Roivant Sciences Ltd. (10% Owner) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Converted 22,833,922 shares
@ $0
Converted 1,164,000 options to buy
@ $7.13, valued at
$8.3M
|
|
| 06/07/2021 |
4
| BURGESS DANIEL D (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 06/07/2021 |
4
| HENRIQUES RICHARD C JR (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 06/07/2021 |
4
| Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 06/07/2021 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 06/07/2021 |
4
| Cheng Andrew (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 06/07/2021 |
4
| Torti Frank (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
|
|
|